A monocentric, open-label single arm prospective clinical study to evaluate the safety and efficacy of Ningen Petunia Radiance Cream on skin radiance, hydration, elasticity and dark spots in healthy adult human females subjects

Arbro Pharmaceuticals Private Limited0 个研究点目标入组 30 人开始时间: 待定最近更新: 2022年11月21日

试验速览

暂无简介。

•Subject must meet all of the following criteriaâ??s in order to be included in the study.
•1. Subject in generally good health.
•2. Subject between the age group of 18 and 55 years.
•3. Subject has not participated in a similar clinical investigation in the past four weeks.
•4. Subject willing to abstain from using any product, besides the provided product during the entire study course.
•5. Subject willing to visit the site at specified frequencies for periodic evaluations.
•6. Subject willing to comply with study specific re requirements.
•7. Subject willing to give a written informed consent and come for regular observation.

•Patient must have none of the following criteria in order to be included in the study.
•1. A known history or present condition of allergic response to any Cosmetic products.
•2. Subject with known allergy/ sensitivity to cosmetic products or fragrance and without any skin allergies infections.
•3. Subject under any dermatological treatment / prescribed medications.
•4. Skin disease (e.g. psoriasis, atopic dermatitis or other cutaneous manifestations on the scalp), which would interfere with the test readings.
•5. Any cutaneous conditions on test site (scars, moles, papules etc.)
•6. On medications (e.g. steroids or antihistamines), which would compromise the study.
•7. Currently or has been undergoing dermatologist facial treatments or procedures within the last 1 month.
•8. Subject viewed by the investigator as not being able to complete the study or participating in another study.

发起方

Arbro Pharmaceuticals Private Limited